Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07088952

Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
572 (estimated)
Sponsor
Vida Recoletas Sevilla · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The rise in frozen embryo transfer (FET) cycles within assisted reproductive technology (ART) has sparked the need to refine endometrial preparation protocols. The switch from hormone replacement cycles (HRT) to natural cycles, poses scheduling challenges onto laboratories, doctors and patients. The modified natural cycle (mNC), offering more precision for scheduling, shows promise but lacks comprehensive data on the potential flexibility of triggering criteria that may allow to control timing in a wider range. This prospective randomized study seeks to address this knowledge gap by evaluating the non-inferiority of triggering ovulation in mNC with follicle diameters of 13-16.9mm compared to the conventional 17-22mm. The study aims to enhance the understanding of the impact of follicle size at ovulation in reproductive outcomes, optimize FET treatments providing a more flexible mNC protocol, and improve patient care in ART clinics.

Conditions

Interventions

TypeNameDescription
PROCEDURETrigger at smaller folicular sizeTrigger indicated at folicular diameter smaller than standard clinical practice, from 13mm to 16.9mm

Timeline

Start date
2025-10-22
Primary completion
2027-07-30
Completion
2028-05-30
First posted
2025-07-28
Last updated
2026-01-13

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07088952. Inclusion in this directory is not an endorsement.